rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 
Rediff.com  » Sports » Harper-Nelson banned after not checking medication properly

Harper-Nelson banned after not checking medication properly

February 08, 2017 09:22 IST

Beijing Olympics 100 metres hurdles champion Dawn Harper-Nelson has been banned for three months after she tested positive for the banned diuretic hydrochlorothiazide, the United States Anti-Doping Agency (USADA) said on Tuesday.

Dawn Harper-NelsonThe ban is effective from Dec. 1, 2016.

USADA said it had accepted Harper-Nelson's explanation that her positive test was caused by medication she was prescribed by a physician to treat hypertension.

"Harper-Nelson further explained that she made efforts to determine if the medication contained prohibited substances; however, due to using partial search terms, those efforts were unsuccessful," USADA said in a statement.

Harper-Nelson, who also clinched silver in the 100 metres hurdles at the 2012 London Games, said the medication had been prescribed after she was taken to hospital suffering from high blood pressure.

"As a result my physician prescribed a non-performance enhancing medication for high blood pressure that contained hydrochlorothiazide, water pill," she wrote on her Twitter page.

"I never hid my use of this required medication, but did fail to fully understand how its administration was governed by current doping protocols.

"I take full responsibility of my mistake and have fully cooperated with IAAF and USADA in the handling of the matter.

"I have learned a valuable lesson and hope my mistake will serve as a reminder to all athletes to be diligent in thoroughly checking any and all prescribed medications." 

Image:  Dawn Harper-Nelson

Photograph: Lucy Nicholson/Reuters

 

Source:
© Copyright 2017 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.